Latest Breaking News On - Supernus pharmaceuticals inc - Page 2 : comparemela.com

Supernus Announces Promising Interim Data from Ongoing Open-Label Phase 2a Study of SPN-817 in Epilepsy

Supernus Announces Promising Interim Data from Ongoing Open-Label Phase 2a Study of SPN-817 in Epilepsy
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Timothyc decPeter vozzoJack khattarJacka khattarDrug administrationSupernus pharmaceuticals incSupernus pharmaceuticalsExchange commissionCompany investor relationsSecurities exchangeAnnounces promising interim dataOngoing open label phaseInvestor relationsOrphan drugDravet syndromeLennox gastaut syndrome

Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc - SUPN

Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc - SUPN
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Tel avivFrance generalUnited statesCity ofUnited kingdomNew yorkAbrahaml pomerantzLos angelesDanielle peytonSupernus pharmaceuticals incCompany new drug applicationPrnewswire pomerantzSupernus pharmaceuticalsComplete response letterNew drug application

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc

/PRNewswire/ Pomerantz LLP is investigating claims on behalf of investors of Supernus Pharmaceuticals, Inc. ("Supernus" or the "Company") (NASDAQ: SUPN)..

City ofUnited kingdomNew yorkUnited statesTel avivFrance generalAbrahaml pomerantzLos angelesDanielle peytonCompany new drug applicationPrnewswire pomerantzSupernus pharmaceuticals incSupernus pharmaceuticalsComplete response letterNew drug application

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus
bdtonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bdtonline.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkCity ofUnited kingdomFrance generalTel avivAbrahaml pomerantzDanielle peytonLos angelesCompany new drug applicationSupernus pharmaceuticals incSupernus pharmaceuticalsComplete response letterNew drug application

Supernus Pharmaceuticals, Inc (NASDAQ:SUPN) Q1 2024 Earnings Call Transcript

Supernus Pharmaceuticals, Inc (NASDAQ:SUPN) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

Tim decPeter vozzoJack khattarSupernus pharmaceuticals incSupernus pharmaceuticals first quarterBiggest oil producing countries in asiaSupernus pharmaceuticalsCall transcript mayResults conferenceInvestor relationsSupernus pharmaceuticalSupernu chief executive officerChief financial officerRisk factorsCelebrities actually wearOil producing countries